(Q40968306)

25 September 2017

Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. (English)

1 reference

25 September 2017

0 references

Kawamura M

1

1 reference

25 September 2017

Ohnishi H

2

1 reference

25 September 2017

Guo SX

3

1 reference

25 September 2017

Sheng XM

4

1 reference

25 September 2017

Minegishi M

5

1 reference

25 September 2017

Hanada R

6

1 reference

25 September 2017

Horibe K

7

1 reference

25 September 2017

Hongo T

8

1 reference

25 September 2017

Kaneko Y

9

1 reference

25 September 2017

Bessho F

10

1 reference

25 September 2017

Yanagisawa M

11

1 reference

25 September 2017

Sekiya T

12

1 reference

25 September 2017

Hayashi Y

13

1 reference

25 September 2017

1 February 1999

1 reference

25 September 2017

1 reference

25 September 2017

23

1 reference

25 September 2017

115-126

1 reference

25 September 2017

2

1 reference

describes a project that uses

25 September 2017

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

Mutations in the p53 gene occur in diverse human tumour types

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

p53 in chronic myelogenous leukemia in acute phase

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

Characterization of a precursor T-cell line (THP-6) with rearranged T-cell receptor beta chain gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

A human CD4- CD8- T-cell receptor alpha beta + T leukemic cell line undergoing phytohemagglutinin-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

Absence of a mutation of the p21/WAF1 gene in human lung and pancreatic cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

Mutations of the RAS genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

Apoptosis in cancer therapy: crossing the threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

Clonal expansion of p53 mutant cells is associated with brain tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

P16 gene in uncultured tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

Mutation analysis of the N-ras proto-oncogene in active and remission phase of human acute leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

Analysis of RAS oncogene mutations in human lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900146-5

7 January 2021

10.1016/S0145-2126(98)00146-5

Identifiers

DOI

1 reference

25 September 2017

1 reference